AI FOR HUMANIZING HEALTH
AI can improve the quality of affordable services, optimize the distribution of resources in underdeveloped and understaffed communities and create inclusive and responsive solutions for
healthcare, diagnosis, triage or treatment decisions. However, it is not enough to deploy these
solutions in the wild. We must also examine how these applications can be used responsibly and
in the context of meeting our goals of having universal health coverage for all.
The 2018 AI for Good Global Summit created the ITU/WHO Focus Group on AI 4 Health, which aims to benchmark AI models in health diagnostics. This year’s AI for Health Solution track will extend this work towards Universal Health Coverage in 2030 and Good Health and Well-Being in general, by identifying new ways in which AI can benefit health.
Speakers, Panelists and Moderators
THOMAS WIEGANDFG-AI4H Chair, Professor, and Executive DirectorFraunhofer Heinrich Hertz InstituteThomas Wiegand is a German electrical engineer who substantially contributed to the creation of the H.264/MPEG-4 AVC and H.265/MPEG-H HEVC video coding standards. For H.264/MPEG-4 AVC, Wiegand was one of the chairmen of the Joint Video Team (JVT) standardization committee that created the standard and was the chief editor of the standard itself. He was also an active technical contributor to both standards. Wiegand also holds a chairmanship position in the ITU-T VCEG and previously in ISO/IEC MPEG standardization organizations. In July 2006, the video coding work of the ITU-T jointly led by Gary J. Sullivan and Wiegand for the preceding six years was voted as the most influential area of the standardization work of the CCITT and ITU-T in their 50-year history. Wiegand is Professor at the Technical University of Berlin and executive director of the Fraunhofer Heinrich Hertz Institute, Berlin, Germany. He heads research teams working on : Video processing and coding, Multimedia transmission, Machine learning, Mobile Communications (management) and Computer Vision (management).
NAOMI LEE FG-AI4H Vice-Chair, Executive Editor; AI for Humanizing Health Solution Track Co-ChairThe Lancet JournalNAOMI LEEFG-AI4H Vice-Chair, Executive Editor; AI for Humanizing Health Solution Track Co-ChairThe Lancet JournalNaomi Lee is Executive Editor (Digital) for The Lancet. Naomi handles peer review and commissioning for The Lancet with a special interest in surgery, health informatics and medical technology. As part of the marketing and communications team, she also leads digital transformation for The Lancet group. Naomi trained in surgery, specializing in urology and has worked in the United Kingdom, Argentina, and Mexico. She studied medicine at Cambridge University and King’s College London, and is currently studying data science at University College London. Naomi joined The Lancet in 2014.
STEFAN GERMANN Chief Executive Officer; AI for Humanizing Health Solution Track Co-ChairFondation BotnarSTEFAN GERMANNChief Executive Officer; AI for Humanizing Health Solution Track Co-ChairFondation BotnarStefan Germann, CEO Fondation Botnar a foundation in Basel Switzerland focusing on child health, nutrition and education. Stefan is tasked as first CEO to set up the management office and lead the foundation in the next stage of it's development. Formerly, Executive Director onegoalglobal.org (an innovative collaborative child nutrition and healthy lifestyle campaign), and Senior Director of World Vision International Sustainable Health Partnership, Innovation and Accountability unit based in Kuala Lumpur, Malaysia. World Vision operates currently in almost 100 countries. He worked for over 15 years in Africa in various health leadership roles with different agencies in the area of child health related development, relief and advocacy work. His worked included managing a large rural hospital in Zimbabwe. In 2005 he started to work with World Vision International’s emergency relief team as the director for the integrated technical sector teams in the Asia Tsunami response. This was a complex relief & reconstruction program where he was based in Asia. This program included major health components, including primary health care rehabilitation in Sri Lanka and mHealth projects for midwives in Aceh, Indonesia. He held a number of board and advisory board memberships (Partnership for Maternal, Newborn and Child Health, UBS Optimus Foundation, REPSSI in Africa) and currently is on the Advisory Board of the Global Health Program, The Graduate Institute – Geneva focusing on the role of NGOs in global health diplomacy. He holds a micro-engineering BSc degree, an MSc degree (Economics) in Social Policy & NGO Management and completed in 2005 a doctoral degree in Development studies focusing on child well-being in urban African context. Stefan finished in 2015 an executive Masters program in Tri Sector Collaboration at Singapore Management University.
SHWETAK PATEL Professor in Computer Science & Engineering, ACM Prize in ComputingUniversity of WashingtonSHWETAK PATELProfessor in Computer Science & Engineering, ACM Prize in ComputingUniversity of WashingtonShwetak N. Patel is the Washington Research Foundation Entrepreneurship Endowed Professor in Computer Science & Engineering and Electrical and Computer Engineering at the University of Washington. His research interests are in the areas of Human-Computer Interaction, Ubiquitous Computing, Sensor-enabled Embedded Systems, and User Interface Software and Technology. His work includes developing new sensing systems, energy and water sensing, mobile health, and developing new interaction technologies. Dr. Patel was also a founder of Zensi, Inc., a demand side energy monitoring solutions provider, which was acquired by Belkin, Inc in 2010. He is also a co-founder of a low-power wireless sensor platform company called SNUPI Technologies and a consumer home sensing product called WallyHome. WallyHome was acquired by Sears in 2015. He received his Ph.D. in Computer Science from the Georgia Institute of Technology in 2008 and B.S. in Computer Science in 2003. Dr. Patel received the MacArthur Foundation Fellowship in 2011, is a 2012 Sloan Fellow, received the TR-35 award in 2009, was named top innovator of the year by Seattle Business Magazine, was named Newsmaker of the year by Seattle Business Journal, and was a recipient of the Microsoft Research Faculty Fellowship in 2011. His past work was also honored by the New York Times as a top technology of the year in 2005. For more information visit Dr. Patel's homepage, and see the Ubicomp Lab website for the latest news, publications, and detailed project descriptions.
SOUMYA SWAMINATHANChief ScientistWorld Health Organization (WHO)Dr Soumya Swaminathan was most recently WHO's Deputy Director-General for Programmes. A paediatrician from India and a globally recognized researcher on tuberculosis and HIV, she brings with her 30 years of experience in clinical care and research and has worked throughout her career to translate research into impactful programmes. Dr Swaminathan was Secretary to the Government of India for Health Research and Director General of the Indian Council of Medical Research from 2015 to 2017. In that position, she focused on bringing science and evidence into health policy making, building research capacity in Indian medical schools and forging south-south partnerships in health sciences. From 2009 to 2011, she also served as Coordinator of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases in Geneva. She received her academic training in India, the United Kingdom of Great Britain and Northern Ireland, and the United States of America, and has published more than 350 peer-reviewed publications and book chapters. She is an elected Foreign Fellow of the US National Academy of Medicine and a Fellow of all three science academies in India. She has previously been on several WHO and global advisory bodies and committees, including the WHO Expert Panel to Review Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property, the Strategic and Technical Advisory Group of the Global TB Department at WHO, and most recently was Co-Chair of the Lancet Commission on TB.
JUDY WAWIRA GICHOYAAssistant ProfessorWinship Cancer Instiute (Emory University)Judy Wawira Gichoya, MD, MS, is Assistant Professor in the Department of Radiology and Imaging Sciences at Emory University School of Medicine. An interventional radiologist, Dr. Gichoya specializes in interventional radiology procedures. Dr. Gichoya is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute. She holds professional memberships with Radiological Society of North America, American College of Radiology, Society of Interventional Radiology, Society of Imaging Informatics in Medicine and American Medical Informatics Association.
AMANDEEP SINGH GILLDirectorGlobal Health CenterAmbassador Amandeep Gill is Director of the Global Health Centre project on International Digital Health & AI Research Collaborative (I-DAIR). Amandeep Gill was Executive Director and co-Lead of the Secretariat of the UN Secretary General’s High-Level Panel on Digital Cooperation until August 2019. He previously served as India’s Ambassador and Permanent Representative to the Conference on Disarmament in Geneva. Ambassador Gill joined the Indian Foreign Service in 1992 and has served at the Indian Missions in Tehran, Colombo, and Geneva. From 2013-2016, he served as Head of the Disarmament and International Security Affairs Division in the Ministry of External Affairs. In 2017, he helped set up the National Task Force on AI for India’s Economic Transformation. Ambassador Gill chaired the Group of Governmental Experts of the Convention on Certain Conventional Weapons (CCW) on emerging technologies in the area of lethal autonomous weapon systems from 2017-2018. He has served on the UN Secretary General’s Advisory Board on Disarmament Matters and on WEF’s Global Futures Council on Values, Ethics, and Innovation; currently he serves as a member of the GFC on Global Public Goods and as a Commissioner on the Lancet/FT Commission on ‘Governing health futures 2030: growing up in a digital world’. Ambassador Gill has a B Tech in electronics and electrical communications from Panjab University, Chandigarh and an Advanced Diploma in French History and Language from Geneva University. His PhD degree from King’s College London is on Nuclear Learning in Multilateral Forums.
PEDRO ANTONIO DE ALARCON SANCHEZSenior Data ScientistTelefonicaMy passion is data science, and its power to solve real-life problems. Most of the projects I've been involved in the last 7 years included machine learning, AI, Big Data with R & Python. I love beautiful visualizations, data journalism and storytelling. I'm fully devoted to demonstrate the awesome potential and value of Telefonica data as well as applying Data for Social Good.
HANS KEIRSTEADChairman and Chief Executive OfficerAIVITA BiomedicalDr. Keirstead is an internationally known stem cell expert and has led therapy development for cancer, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. He is the Chairman and CEO of AIVITA Biomedical. He was previously CSO of Caladrius which acquired California Stem Cell in 2014. Dr. Keirstead founded California Stem Cell, served as CEO, and led 3 rounds of the investment and sale of the Company. He holds Board positions in several prominent biotechnology companies. Previously, he founded and served as the CEO of Ability Biomedical, which developed technology later sold to Bristol Myers Squibb. He was a Professor at the University of California, Irvine where he founded and directed the $77 million Sue and Bill Gross Stem Cell Research Center. As a Full Professor of Anatomy and Neurobiology, he was awarded over $16 million in grants during his 15-year tenure. He has mentored over 100 students, published over 100 manuscripts, and granted over 20 patents. He was awarded the Distinguished Award for Research, the UCI Academic Senate’s highest honor, as well as the UCI Innovation Award for innovative research leading to corporate and clinical development. He was a founding advisor of the California Stem Cell Initiative that resulted in a $3 billion stem cell fund (CIRM). He has been a long-time advisor to several governments on biomedical policy. Dr. Keirstead has been a notable figure in the field of regenerative medicine for over two decades. His work in spinal cord injury earned him the distinction of being one of 100 top scientists of the year in Discover Magazine. He was featured on 60 minutes in a full segment covering his treatment for spinal cord injury. Dr. Keirstead and his research have also appeared in Newsweek, Inc. Magazine, WIRED, Esquire, The NY Times, TIME Magazine, Men’s Vogue, Science and The American Spectator, amongst other national publications. He has given dozens of keynote addresses at industry meetings and events, was a TEDx speaker, and was recently honored as one of 7 thought leaders in Canada at the Seven Wonderer’s event by Beakerhead. Dr. Keirstead received his Ph.D. in neuroscience from the University of British Columbia, Canada for which he received the Cameron Award for the outstanding Ph.D. thesis in the country. He conducted Post-Doctoral studies at the University of Cambridge. He received the distinct honor of election as Senate Member of the University of Cambridge and Fellow of the Governing Body of Downing College, and was the youngest member to have been elected to those positions.
- 9:00 - 10:15
- Part 1
- ''AI for Health" and Keynotes
Speakers:THOMAS WIEGAND , SOUMYA SWAMINATHAN
- 10:15 - 11:00
- Coffee break